journal article·2025-08Open access

Injectable hyaluronic acid hydrogel for corneal neovascularization management by inhibiting oxidative stress, inflammation and neovascularization

Yingying Wei, Jiahao Xu, Xu Yang, Qing Wang, Linyu Long, Daihua Fu, Fanjun Zhang, Shibo Tang, Yunbing Wang

Materials & Design· Volume 256

Abstract

Corneal neovascularization (CNV) represents a significant global contributor to vision impairment and blindness. Nonetheless, existing therapeutic modalities, including surgical interventions and pharmacological treatments, face challenges related to limited efficacy and potential adverse effects. In this study, we developed a hydrogel formulation for the targeted delivery of the anti-angiogenic peptide KV11 leveraging multiple physicochemical interactions among adipic dihydrazide-modified hyaluronic acid (AHA), protocatechuic aldehyde (PA), and MnO 2 . The incorporation of PA and MnO 2 conferred antioxidant properties to the hydrogel, enabling it to effectively scavenge DPPH free radicals and hydroxyl radicals. Therefore, the hydrogel demonstrated notable antioxidant and anti-apoptotic effects in human corneal epithelial cells (HCECs) and effectively inhibited M1 macrophage polarization in vitro . Additionally, the hydrogel formulation was capable of suppressing the migration and proliferation of endothelial cells. Treatment with the KV11-loaded hydrogel significantly ameliorated pathological corneal injury in a rat model of alkali burn-induced CNV. Furthermore, the hydrogel material demonstrated safety and non-toxicity to the ocular surface. This study designed a multifunctional HA hydrogel formulation by integrating materials with antioxidant properties, specifically PA and MnO 2 , along with KV11, effectively addressing the complex challenges posed by oxidative stress, acute inflammatory responses, and neovascularization, providing a promising strategy for the treatment of CNV.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Corneal Surgery and Treatments · Corneal surgery and disorders · Ocular Surface and Contact Lens

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Recent advances in NLRP3 inflammasome in corneal diseases: preclinical insights and therapeutic implications10.1016/j.jtos.2024.09.007 ↗
2. Regenerative therapy for the Cornea10.1016/j.preteyeres.2021.101011 ↗
3. Minocycline-loaded nHAP/PLGA microspheres for prevention of injury-related corneal angiogenesis10.1186/s12951-024-02317-7 ↗
4. Topical application of 666-15, a potent inhibitor of CREB, alleviates alkali-induced corneal neovascularization10.1016/j.exer.2024.110165 ↗
5. Naringenin eye drops inhibit corneal neovascularization by anti-inflammatory and antioxidant mechanisms10.1167/iovs.16-19702 ↗
6. Suppression of pathological neovascularization by anti-Flt1 peptide functionalized DNA tetrahedron10.1016/j.cej.2024.153249 ↗
7. Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization10.1016/j.jconrel.2024.07.012 ↗
8. Hydrogen and N-acetyl-l-cysteine rescue oxidative stress-induced angiogenesis in a mouse cornealalkali-burn model10.1167/iovs.10-6167 ↗
9. Dasatinib and erianin co-loaded ion-responsive in-situ hydrogel for effective treatment of corneal neovascularization10.1016/j.jconrel.2024.10.001 ↗
10. Histone methylation regulates neutrophil extracellular traps to attenuate corneal neovascularization10.1016/j.intimp.2024.113525 ↗
11. Genome editing VEGFA prevents corneal neovascularization in vivo
12. Available therapeutic options for corneal neovascularization: a review10.3390/ijms25105479 ↗
13. Harnessing silk fibroin microparticles for metformin delivery: a novel approach to treating corneal neovascularization10.1016/j.jddst.2024.105625 ↗
14. Engineered mesenchymal stromal cell exosomes-loaded microneedles improve corneal healing after chemical injury10.1021/acsnano.4c00423 ↗
15. Alginate-functionalized nanoceria as ion-responsive eye drop formulation to treat corneal abrasion10.1016/j.carbpol.2024.123164 ↗
16. Q. Qi, D. Su, S. Zhuang, S. Yao, L.M. Heindl, X. Fan, M. Lin, J. Li, Y. Pang, Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology, Advanced Science n/a(n/a) (2025) 2407340. https://doi.org/https://doi.org/10.1002/advs.202407340.10.1002/advs.202407340 ↗
17. Anti-inflammatory and Restorative effects of milk exosomes and dexamethasone-loaded exosomes in a corneal alkali burn model10.1016/j.ijpharm.2024.124784 ↗
18. Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization10.7150/thno.65098 ↗
19. CXCR3 deletion aggravates corneal neovascularization in a corneal alkali-burn model10.1016/j.exer.2022.109265 ↗
20. A SU6668 pure nanoparticle-based eyedrops: toward its high drug accumulation and long-time treatment for corneal neovascularization10.1186/s12951-024-02510-8 ↗
21. A synergistic therapy with antioxidant and anti-VEGF: toward its safe and effective elimination for corneal neovascularization10.1002/adhm.202302192 ↗
22. Ophthalmic gels: past, present and future10.1016/j.addr.2017.12.017 ↗
23. Imatinib@glycymicelles entrapped in hydrogel: preparation, characterization, and therapeutic effect on corneal alkali burn in mice10.1007/s13346-024-01570-5 ↗
24. Advances in polysaccharide-based microneedle systems for the treatment of ocular diseases10.1007/s40820-024-01477-3 ↗
25. Tailoring hyaluronic acid hydrogels for biomedical applications10.1002/adfm.202306554 ↗
26. Macrophage-disguised manganese dioxide nanoparticles for neuroprotection by reducing oxidative stress and modulating inflammatory microenvironment in acute ischemic stroke
27. Theoretical study of antioxidant and prooxidant potency of protocatechuic aldehyde10.3390/ijms26010404 ↗
28. Biomimetic hydrogel containing copper sulfide nanoparticles and deferoxamine for photothermal therapy of infected diabetic wounds10.1002/adhm.202303000 ↗
29. In situ cross-linkable hydrogel of hyaluronan produced via copper-free click chemistry10.1021/bm4009606 ↗
30. Synergistic osteogenic and angiogenic effects of KP and QK peptides incorporated with an injectable and self-healing hydrogel for efficient bone regeneration
31. Fullerenol protects cornea from ultraviolet B exposure10.1016/j.redox.2022.102360 ↗
32. Fabrication of carboxymethyl cellulose-based thermo-sensitive hydrogels and inhibition of corneal neovascularization10.1016/j.ijbiomac.2024.129933 ↗
33. Dual-atom nanozyme eye drops attenuate inflammation and break the vicious cycle in dry eye disease10.1007/s40820-024-01322-7 ↗
34. Anti-inflammatory dressing based on hyaluronic acid and hydroxyethyl starch for wound healing10.1016/j.ijbiomac.2024.137078 ↗
35. Structural design of a hyperbranched chitosan-based bioplastic with excellent strength, antibacterial, and UV shielding performance10.1016/j.cej.2023.144687 ↗
36. Dual dynamic crosslinked hydrogel patch embodied with anti-bacterial and macrophage regulatory properties for synergistic prevention of peritendinous adhesion10.1002/adfm.202400660 ↗
37. The pH-sensitive optical fiber integrated CMCS-PA@Fe hydrogels for photothermal therapy and real-time monitoring of infected wounds10.1002/adfm.202212803 ↗
38. A MnO2 nanoparticle-dotted hydrogel promotes spinal cord repair via regulating reactive oxygen species microenvironment and synergizing with mesenchymal stem cells10.1021/acsnano.9b07598 ↗
39. Biosafe polydopamine-decorated MnO2 nanoparticles with hemostasis and antioxidative properties for postoperative adhesion prevention10.1021/acsbiomaterials.3c01413 ↗
40. Antioxidant and antibacterial hydrogel formed by protocatechualdehyde–ferric iron complex and aminopolysaccharide for infected wound healing10.1016/j.ijbiomac.2024.131642 ↗
41. J.B. Jeong, S. Chul Hong, H. Jin Jeong, 3,4-Dihydroxybenzaldehyde purified from the barley seeds (Hordeum vulgare) inhibits oxidative DNA damage and apoptosis via its antioxidant activity, Phytomedicine 16(1) (2009) 85-94. https://doi.org/https://doi.org/10.1016/j.phymed.2008.09.013.10.1016/j.phymed.2008.09.013 ↗
42. Up-to-date molecular medicine strategies for management of ocular surface neovascularization10.1016/j.addr.2023.115084 ↗
43. The emerging role of nanozymes in ocular antioxidant therapy10.1016/j.nantod.2024.102448 ↗
44. Ferroptosis and PANoptosis under hypoxia pivoting on the crosstalk between DHODH and GPX4 in corneal epithelium10.1016/j.freeradbiomed.2024.12.050 ↗
45. Mitochondria-targeted SkQ1 nanoparticles for dry eye disease: inhibiting NLRP3 inflammasome activation by preventing mitochondrial DNA oxidation10.1016/j.jconrel.2023.11.021 ↗
46. Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model10.1016/j.intimp.2023.109680 ↗
47. Macrophage plasticity, polarization, and function in health and disease10.1002/jcp.26429 ↗
48. The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells10.1167/iovs.12-11068 ↗
49. Ferrostatin-1-loaded liposome for treatment of corneal alkali burn via targeting ferroptosis10.1002/btm2.10276 ↗
50. Phytic acid-loaded polyvinyl alcohol hydrogel promotes wound healing of injured corneal epithelium through inhibiting ferroptosis10.1016/j.redox.2024.103354 ↗
51. Unveiling the power of gabapentin-loaded nanoceria with multiple therapeutic capabilities for the treatment of dry eye disease10.1021/acsnano.3c07817 ↗